4.4 Article

Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells

期刊

RESPIRATION
卷 75, 期 2, 页码 202-209

出版社

KARGER
DOI: 10.1159/000111569

关键词

chronic obstructive pulmonary disease; erythromycin; glutathione; interleukin-8; oxidative stress; gamma-GCS

向作者/读者索取更多资源

Background: Macrolide antibiotics have anti-inflammatory effects which are utilized for the treatment of chronic inflammatory airway diseases. Recently, their anti-inflammatory effects have been proposed to be beneficial in patients with chronic obstructive pulmonary disease (COPD). Objectives: Since the molecular mechanisms of anti-inflammatory effects are associated with inhibition of activator protein 1 (AP-1) and nuclear factor (NF)-kappa B, and both are reported to be involved in the expression of gamma-glutamylcysteine synthetase (gamma-GCS), we set out to determine if these drugs influence the oxidant-antioxidant balance in human bronchial epithelial (HBE) cells. Methods: 16HBE cells were preincubated with erythromycin (EM) at different concentrations and times and then exposed to hydrogen peroxide (0.01 mM). Levels of interleukin (IL)-8 and glutathione (GSH), and activity of gamma-GCS and gamma-GCS heavy subunit (gamma-GCS-HS) protein production were assayed. AP-1 and NF-kappa B binding to the 5'-flanking region of IL-8 and gamma-GCS-HS genes was assessed by electrophoretic mobility-shift assay. Results: The increase in IL-8 levels and activity of AP-1 induced by H2O2 were abrogated by preincubation of the cells with EM (5 mu g/ml) for 36 h. We also showed that preincubation with EM for 48 h inhibited H2O2-induced GSH levels, gamma-GCS activity and expression of gamma-GCS-HS, and decreased AP-1 binding to the gamma-GCS-HS 5'-flanking region. Conclusions: The confirmation of antioxidants maintaining enzyme suppression by EM raised concerns on whether this drug could disrupt the oxidant/antioxidant balance during long-term use. These data provide important insights into the treatment of inflammatory lung diseases with macrolide antibiotics. Copyright (C) 2007 S. Karger AG, Basel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据